Summary.-The synthesis and localization of collagen have been studied on material from a total of 16 primary Ewing's tumours. The predominant collagen extracted from the tissues and synthesized in short-term cultures was type I. The proportion of type III collagen was relatively small and variable (0-8%) in the direct tumour extracts, but a higher proportion (29-38% of the total collagens) was synthesized in culture. Immunofluorescence studies showed that positive staining for all types of collagen tested (types I, III, IV and V) was restricted to stroma; there was no evidence of collagen either within the tumour cells or in their pericellular matrix, a finding endorsed by negative staining for reticulin in the same areas. The absence of any evidence for type IV or V collagen synthesis by Ewing's cells argues against an endothelial origin for the tumour, and indicates that collagen analysis is unlikely to be of value in the diagnosis of this particular sarcoma.
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DURING THE LAST DECADE, 5 genetically distinct collagens, designated types I-V, have been recognized. Their molecular form and characteristic tissue distribution are summarized in the Table. The individual collagen types can now be identified by both biochemical and immunological techniques, and this has led to a greater understanding of the pathology of such diseases as the inherited defects of collagen synthesis (Prockop et al., 1979) .
The so-called "small round-cell tumours" of bone or of soft tissue are a frequent source of diagnostic difficulty to histopathologists. Sometimes conventional histopathological techniques fail to distinguish Ewing's sarcoma from metastatic neuroblastoma, rhabdomyosarcoma, socalled "reticulum-cell sarcoma" and, occasionally, small-cell osteogenic sarcoma (Ball et al., 1977) . In addition, the histogenesis of Ewing's sarcoma is still a source of contention. Ewing himself (Ewing, 1921) considered that the tumour cells were derived from endothelium, but others have suggested an origin from a bone-marrow stem cell (Kadin & Bensch, 1971) .
Since immunological investigation of collagen in osteogenic sarcoma revealed that malignant osteoblasts retained the collagen phenotype of normal osteoblasts, i.e. synthesized type I collagen (Remberger & Gay, 1977) , we set out to determine if analysis of collagen in Ewing's sarcoma would yield information relevant to the diagnosis or histogenetic origin of the tumour. To do this we used biochemical and immunofluorescence methods to identify and localize collagen in frozen tissue and short-term cultures from Ewing's tumours.
METHODS AND MATERIALS
Tumour material.-Tissue was obtained from primary tumours of 16 patients, of whom 12 had had no prior treatment and 3 had received pulsed chemotherapy (2, 4 or 6 Collagen analysis.-Collagens were extracted directly from the tissues, or from the cultured tissues combined with their media and 100 ,ug of acid-soluble rat skin collagen as carrier, by homogenization in 0-5M acetic acid at 4°C, followed by pepsin digestion (1 mg/ml) for 24 h. Insoluble material was resuspended in fresh acetic acid and pepsin, digested for a further 24 h and centrifuged. The supernatant was added to the first extract, and any remaining insoluble material was hydrolysed at 1100C in 6N 1I1 for 16 h and analysed for hydroxyproline using an automated colorimetric assay (Bannister & Burns, 1970) .
Collagens were purified by precipitating twice from acidic solution by addition of 1-6M NaCl, then dialysed against 0-5M acetic acid and lyophilized.
Identification of radioactively-labelled collagens by carboxymethyl cellulose (CMC) chromatography was performed as described previously (Webster & Harvey, 1979) . Approximately 80,000 dpm of each 3H-labelled collagen sample was dissolved with 2 mg of carrier acid-soluble rat-skin collagen in 0-06M acetate buffer, pH 4-8, containing IM urea, and applied to a 6-0 x 1 5cm column of CM 52 (Whatman) maintained at 450C.
Collagens were eluted with an increasing gradient of 0-015M NaCl over a total volume of 200 ml. Fractions (1.6 ml) were collected and radioactivity measured after addition of 3-0 ml scintillant (Unisolve 1, Koch-Light).
Radioactively-labelled collagens were also analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) using rod gels (10 x 0u5 cm, 5% acrylamide, 0.05% bis-acrylamide in 80mM tris-borate buffer, pH 8.6). Samples of 70,000 dpm were dissolved in the above buffer containing IM urea, 2% glycerol and a trace of bromophenol blue as marker dye. Electrophoresis was performed in the buffer described above at 1 mamp/gel and the gels were subsequently sliced into 1mm-thick discs before alkaline hydrolysis and measurement of radioactivity (Webster & Harvey, 1979) .
Analysis of collagens extracted from native tumour tissue was performed by SDS PAGE with slab gels (14 x 16 x 0415 cm) using acrylamide and buffer as described above. Collagen samples were dissolved at 2 mg/ml in sample buffer and duplicate 20,u1 samples were loaded into adjacent lcm wells and electrophoresed at 20 mamp/gel. Separation of type III collagen chains from type I was achieved by a delayed-reduction technique (Sykes et at., 1976) : after 20 min the electrophoresis was stopped and 20 tl of a 20% (v/v) solution of 2-mercaptoethanol in sample buffer was added to one of each pair of sample wells (Fig.  1 , tracks 2 and 4), and allowed to diffuse into the gel for 30 min before electrophoresis was restarted. This procedure reduces disulphide bonds and causes the cx chains of type III collagen to migrate at the same speed as, but behind, the xl chains of type I collagen. The gels were fixed and stained in a 0-15% solution of Coomassie blue R 250 in 12°, trichloracetic acid, and destained in 7.50/a acetic acid. Each track was then scanned in a Joyce-Loebl 200 densitometer with a lcm slit length and a 570-580 nm filter. The collagen bands were quantitated by planimetry, and the proportion of type III collagen expressed as a percentage of the total.
Immunofluorescence studies.-Serial cryostat sections (3-4 ,um) were stained for each of the 4 collagen types under study, and also with haematoxylin and eosin. Type-specific antisera to human collagen types I and III were raised in goats, and antisera to types IV and V in rabbits. Details of the preparations and specificity of antisera to types I, III and IV collagens are described by Duance et al. (1977) , and antiserum to type V collagen by Bailey et al. (1979) .
To identify type I and type III collagen, sections were pre-incubated in a 1:10 dilution of normal rabbit serum and then exposed to goat anti-collagen antibodies at a dilution of 1:100 for 12-18 h at 4°C. The sections were then washed with phosphate-buffered saline (PBS) and incubated with fluoresceinconjugated rabbit anti-goat antibodies (SeraLab) at a dilution of 1:20 for 2 h at 20°C. The sections were washed in PBS, mounted in glycerine jelly, and examined with a Zeiss Universal microscope using epi-illumination from a Zeiss 100 UV illuminator.
For identification of collagen types IV and V the sections were treated as above except for pre-incubation with pig serum, incubation with rabbit anti-collagen antibodies and staining with fluorescein-conjugated pig antirabbit serum (Dako) at 1:20 dilution. Control sections were incubated with normal goat serum or normal rabbit serum at 1: 100 dilution in place of the anti-collagen antibodies.
RESULTS
The proportion of collagen in the tumour tissues was high (30-50 mg/g wet wt) and it was completely solubilized by the limited pepsin digestion. In some preparations a trace of insoluble residual material was found after centrifugation of the second pepsin digest. This material contained no detectable hydroxyproline. Electrophoresis showed that the extracted collagen was predominantly type I (Fig.  1) (Fig. 2) . Sections stained for reticulin showed heavy silver deposition in the connective-tissue stroma and some blood vessels, but no staining of the tumour cells or their intercellular matrix (Fig. 3) .
Antibodies to type I (Fig. 4a) collagen and to type III collagen (Fig. 4b) produced a similar pattern of intense fluorescent staining, localized mainly in the dense connective-tissue stroma, but occasionally observed around small blood vessels between the tumour cells. The tumour cells and the matrix immediately around the tumour cells were negative. Antibodies to type IV (Fig. 4c) and type V collagen (Fig. 4d) showed clear staining of basement membranes around blood vessels and some fibres in the adjacent connective tissue, but no staining in or around tumour cells themselves. No distinct differences between the localization of types IV and V were identified in these preparations. Collagen synthe8is in vitro The tumour tissues synthesized collagen during the 24h-culture period, and the radioactively-labelled chains were identified by CMC chromatography (Fig. 5 ) and SDS PAGE (Fig. 6 ) by their co-elution and co-migration, respectively, with standard collagens from rat skin or radioactivelylabelled human dermal fibroblast cultures. Recovery of radioactive collagen from CMC chromatography was consistently > 90%0, due to pre-treatment of the CMC with an excess of rat-skin collagen (Webster & Harvey, 1979) .
The newly-synthesized collagen was largely type I, with type III contributing 29-38% of the total. There was evidence of type V collagen synthesis, demonstrated by the small peak migrating in the position of (xI(V) on SDS PAGE (Fig. 6 ). The contribution of this peak was approximately 300 of the total. The ratio of 853 radioactivity in the xl(I) peak to that in the a2 peak calculated from chromatographic and electrophoretic profiles ranged from 2-3:1 to 3-4:1.
DISCUSSION
In this study we have found that the collagen extracted from Ewing's tumours was predominantly type I, with a small and variable amount of type III. The collagen synthesized by tumour tissues in short-term cultures was also predominantly type I, but the percentage of type III collagen (29-38%) was markedly higher than that extracted from the parent tumour tissue. The relative rates of synthesis or degradation of type I and type III collagen were therefore altered when the tissue was cultured. The ratio of 1z: A2 chains of radioactively-labelled collagen was higher than the ratio of 2:1 expected for type I collagen. This may have been due to unequal incorporation of 3H-proline into the cxl and Ao2 chains or may reflect the synthesis of some type I trimer (od(I)3).
Since histopathological examination of all the tumours revealed considerable infiltration by stromal fibroblasts cells known to synthesize both type I and type III collagen (Gay et al., 1976) it was critical to determine the cellular origin of the collagens found and synthesized in the tumours. The immunofluorescence studies ( Fig. 4a-d) showed no collagen types I, III, IV or V either in the tumour cells themselves or in their extracellular matrix. These collagens were apparently restricted to the connective-tissue stroma and blood vessels. The absence of type III collagen from the tumour cell matrix in our immunofluorescence studies was supported by the negative reticulin stain (Fig. 3) . Immunologically reactive type III collagen has been described in a wide range of bone and cartilage tumours (Remberger & Gay, 1977) , but the absence of cytoplasmic staining for type III collagen led these authors to conclude that the accompanying vascular stroma, rather than the tumour cells themselves, were the sites of type III collagen synthesis; our results confirm this to be the case in Ewing's sarcoma. The apparent formation of bone in Ewing's tumour with positive immunofluorescence to type I collagen reported by Remberger & Gay (1977) could be explained by the synthesis of reactive osteoid derived from normal osteoblasts. We have found no evidence for bone formation by Ewing's tumour cells. Ewing (1921) described the tumour bearing his name as an "endothelial myeloma." However, Ewing's tumours lack the vascular elements and extracellular material which are characteristic of neoplasms of true angioblastic origin such as hemangioendothelioma (Stout, 1943) or angiosarcoma recently described by Bednar (1980) . This has led others (e.g. Kadin & Bensch, 1971) to reject the concept of an endothelial origin and postulate that Ewing's tumour is a myelogenous neoplasm, possibly of multifocal origin. Our own findings do not suggest a vascular origin of the tumour, and contrast with a brief report of immunofluorescent staining with antibodies to type IV collagen in Ewing's tumour (Roessner et al., 1980) and with a report that a cell line derived from a Ewing's tumour synthesized type I and type III procollagens as well as fibronectin (Stern et al., 1980) . Cells of endothelial origin would be expected to synthesize type IV collagen-a characteristic basement-membrane component and possibly type V in culture (Howard et al., 1976; Madri et al., 1980) , but endothelial cells have also been reported to synthesize type I and type III collagen in vitro (Barnes et al., 1978) . This diversity of collagen phenotype between different endothelial cell cultures emphasizes that patterns of collagen synthesis by cells in vitro should be interpreted with caution.
In conclusion, our studies indicate that (i) biochemical and immunofluorescent analysis of collagen is unlikely to be helpful to the histopathologist in the differentiation of Ewing's sarcoma from 854 other small round-cell tumours, although the use of immunofluorescence to indicate the absence of type I collagen in tumour cells could occasionally be used to differentiate Ewing's tumours from osteogenic sarcoma, and (ii) that Ewing's sarcoma is unlikely to be of vascular endothelial origin.
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